Navigation Links
Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
Date:11/2/2009

g uncertainties in the regulatory process, among other uncertainties. For further details about these and other factors that may impact the forward-looking statements, see Schering-Plough's Securities and Exchange Commission filings, including Part II, Item 1A. "Risk Factors" in the Company's third quarter 2009 10-Q, filed October 29, 2009.

    Endnote

    [1] Vierling J, Poordad F, Lawitz E, et al. Once-Daily Narlaprevir (SCH 900518) in Combination with Peginterferon alfa-2b/Ribavirin for Treatment-Naive Patients with Genotype-1 Chronic Hepatitis C: Interim Results from the NEXT-1 Study. American Association for the Study of Liver Diseases (AASLD) Annual Meeting; Oct. 30-Nov. 3, Boston, MA, USA; oral presentation, Late-Breaker Abstract No. LB4.

    SOURCE Schering-Plough Corporation


    '/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
2. Pharmacopeia Earns Milestone Payment From Schering-Plough on Initiation of Phase 1 Clinical Trials of Novel Therapeutic Candidate
3. Schering-Plough Highlights PEGINTRON(TM) Clinical Data Presentations at the American Association for the Study of Liver Diseases (AASLD) 2007 Annual Meeting
4. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
5. Schering-Plough Reports Top-Line Results of the IDEAL Study
6. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
7. Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients
8. Schering-Plough Announces Imperfect Contraceptive Use Impacts Womens Emotional Well-Being
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Data Presentations at European Association for the Study of the Liver (EASL) Annual Meeting
10. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Flextronics (Nasdaq: FLEX ) ... previously announced acquisition of SloMedical S.R.O., a ... ranging from tubing sets to complex devices ... Flextronics provides a broad set of capabilities ... customers. Terms of the deal were not ...
(Date:12/15/2009)... -- Cumberland Pharmaceuticals Inc. ( CPIX) ... results for a patient preference study evaluating Kristalose ... laxative packaged as a crystalline powder, compared to ... the only prescription-strength laxative available in pre-measured powder ... a recent diagnosis of chronic constipation were administered ...
(Date:12/15/2009)... Dec. 15 Certified healthcare providers who ... complications from the H1N1 flu virus may now ... the Department of Health announced today. ,, ... everyone because approximately 3.2 million doses of vaccine ... it to individuals in the priority groups. ,, ...
Breaking Medicine Technology:Flextronics Completes SloMedical Acquisition 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 2Kristalose(R) Preferred by Patients With Chronic Constipation Compared to Similar Products in a Recent Study 3Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients 2Upending textbook science on Alzheimers disease 61940 1Upending textbook science on Alzheimers disease 61940 2Killer fungus threatening amphibians 10867 1NIGMS invests in scientific Grand Opportunities with Recovery Act funds 10865 1NIGMS invests in scientific Grand Opportunities with Recovery Act funds 10865 2NIGMS invests in scientific Grand Opportunities with Recovery Act funds 10865 3
... Use of Fujirebio Diagnostics, , HE4 Test with CA125 ... Pa., Jan. 26 A pivotal clinical trial published ... Gynecologic Oncology demonstrated the utility of combining Fujirebio ... in estimating the risk of epithelial ovarian cancer in ...
... Identified, Versus MenNEW YORK, Jan. 26 Hypertrophic Cardiomyopathy ... thickening of the heart wall muscle and is the ... young adults (<40). More importantly, although heart disease ... Cardiomyopathy Association ( www.4HCM.org ) warns women remain untreated ...
Other Medicine Technology:Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass 2Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass 3Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass 4Cardiac Disease in Women Remains Untreated for Decades 2
(Date:12/15/2009)... 15 SUMMARY: The U.S. ... Protection and Affordable Care Act that would have ... for the safe and legal importation of lower ... by AARP and sponsored by Senators Dorgan, Snowe, ... and helped to bring down the skyrocketing costs ...
(Date:12/15/2009)... (OTC Bulletin Board: SNKTY), a Life Sciences company engaged in the research, development and commercialization ... all three resolutions that the Company had proposed at the Annual General Meeting of Shareholders ... Description of Votes ... Votes Non-, Matter ... For Against ...
(Date:12/15/2009)... Calif., Dec. 15 Palo Alto Networks(TM), ... University has deployed its PA-4000 Series next-generation firewalls ... and for enhanced visibility and control over applications ... is a Japanese national university with eight facilities ... 1949 by integrating a number of academic schools ...
(Date:12/15/2009)... be donated to the Lupus Foundation of America and ... Dec. 15 Julian Lennon, son of the ... their new digital single, "LUCY," to raise funds for ... 15, 2010, 100 percent of the proceeds from downloading ... Foundation of America (LFA), and the Saint Thomas, Lupus ...
(Date:12/15/2009)... YORK, Dec. 15 Vitech Systems Group, ... Relationship Management (CRM) software, announced today that it ... implementation for the Screen Actors Guild-Producers Pension & ... advanced customer service capabilities to SAG-PH call center ... system was installed using Vitech,s V3 Benefits Administration ...
Breaking Medicine News(10 mins):Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 2Health News:Senetek PLC Announces 2009 Annual General Meeting Voting Results 3Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 2Health News:Palo Alto Networks Next-Generation Firewalls Deliver High-Performance Network Protection for Shinshu University 3Health News:Julian Lennon and James Scott Cook Release New Charity Single 'LUCY' to Raise Awareness and Funds for Lupus Research 2Health News:Screen Actors Guild - Producers Pension & Health Plans Live on New CRM Solution 2
... disease care, study finds , , TUESDAY, Oct. 2 (HealthDay ... rates of chronic disease in the United States, with ... a new study finds. , It,s an expensive problem, ... and heart disease account for some $100 to $150 ...
... MIT Holding, Inc. (OTCBB: MITD - News), has signed ... to stop the spread of infectious diseases. Dr. ... and Director of the Biodefense and Infectious Disease Laboratory ... College of Public Health, Georgia Southern University, will oversee ...
... PA, October 2, 2007 The first significant genetic ... reported. PMDD is a very severe form of ... PMDD is heritable, affects 5-8% of women, and is ... irritability, marked depressed mood, anger, headaches, weight gain and ...
... /PRNewswire/-- Meretek Diagnostics, Inc. and,Otsuka America Pharmaceutical, Inc. ... the two companies. The merger forms a new ... America Pharmaceutical,Inc. OAPI was established in 1989 ... by Otsuka Pharmaceutical Co., Ltd. (OPC). Meretek Diagnostics,was ...
... Fibertec, a division of,Filtrona plc, developer of fiber-based ... celebrated the completion,of the recent expansion of its ... (Logo: http://www.newscom.com/cgi-bin/prnh/20061127/DCM011LOGO ) The ... the size of,production floor space and an expanded ...
... TOWN, W.V., Oct. 2 /PRNewswire-FirstCall/-- ReBuilder Medical,Technologies, Inc. ... the,increasing demand for its products it has had ... in the past three weeks alone. (Logo: ... PhD, CEO of ReBuilder, stated, "We have been,marketing ...
Other Medicine News:Health News:Obesity Driving Rising U.S. Health Costs 2Health News:Obesity Driving Rising U.S. Health Costs 3Health News:First significant genetic finding in severe PMS, or PMDD 2Health News:Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger 2Health News:Filtrona Fibertec Ningbo, China Plant Celebrates Expansion 2Health News:ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products 2Health News:ReBuilder Medical Technologies, Inc. Increases Staffing by 30% in Three Weeks Due to Increase in Demand for All ReBuilder Medical Products 3
... ACTH (adrenocorticotropic hormone) is synthesized in ... gland and is secreted into the peripheral ... approximately 20 minutes [1]. ACTH is secreted ... the hypothalamus [1]. The actions of CRF ...
... chorionic gonadotropin (hCG) is a two chain ... the chorionic tissue of the placenta and ... during pregnancy. Produced by the trophoblastic epithelium ... the corpus luteum in the early stages ...
... for movement is critical ... wheelchairs. Thats why this ... technology to do just ... state-of-the-art technology, these wheelchair ...
... Medicals AUDICOR is the first, easy-to-use, ... worldwide quickly rule-in cardiac dysfunction including ... and other high-risk cardiac conditions. Designed ... workflow, AUDICOR products enable clinicians caring ...
Medicine Products: